Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Liposomes containing drugs for treatment of vaginal infections (CROSBI ID 90006)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Pavelić, Željka ; Škalko-Basnet, Nataša ; Jalšenjak, Ivan Liposomes containing drugs for treatment of vaginal infections // European journal of pharmaceutical sciences, 8 (1999), 345-351-x

Podaci o odgovornosti

Pavelić, Željka ; Škalko-Basnet, Nataša ; Jalšenjak, Ivan

engleski

Liposomes containing drugs for treatment of vaginal infections

To develop a novel vaginal delivery system, able to effectively deliver entrapped drugs during an extended period of time at the site of action, liposomes made of phosphatidylcholine were prepared by two different methods, namely the polyol dilution method and the proliposome method. Liposomes containing three commonly applied drugs in the treatment of vaginal infections: clotrimazole, metronidazole and chloramphenicol were tested for in vitro stability (in buffers at pH 4.5 and 5.9 representing pre- and postmenopausal vaginal pH). In situ stability (in the presence of cow vaginal mucosa) showed that after 6 h incubation (at 37 degrees C), liposomes retained more than 40% of originally entrapped clotrimazole, 28% of entrapped metronidazole or 37% of entrapped chloramphenicol. In vitro and in situ stability studies confirmed the applicability of liposomes as a carrier system for vaginal delivery. Even after 24 h of incubation in the presence of vaginal mucosa liposomes retained sufficient amounts of entrapped drugs. (C) 1999 Elsevier Science B.V. All rights reserved.

Liposomes. Clotrimazole. Metronidazole. Chloramphenicol. Vaginal application.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

8

1999.

345-351-x

objavljeno

0928-0987

Povezanost rada

Farmacija

Indeksiranost